Abstract

Abstract Peripheral sensory neurons are afferent neurons that innervate the skin, joints, bones, muscles, and mucosal tissues. By converting different stimuli into action potentials, they transmit signals for the sensing of temperature, touch, pressure, or pain. This review discusses the known Mendelian disorders which affect pain sensing in humans. For painlessness, these disorders can be classified as developmental, neurodegenerative, or functional, where pain-sensing neurons (nociceptors) are present but cannot be activated or produce action potentials. Affected patients suffer from numbness with recurrent injuries, burns, and poorly healing wounds. For Mendelian disorders of excess pain, aberrant overactivity of nociceptors is a hallmark and leads to paroxysmal or continuous pain states. Again, the effect can be functional or, as in small fiber neuropathies, can be accompanied by degeneration of small unmyelinated nerve fibers in the skin. About 20 different genes are known to cause Mendelian pain disorders and the molecules involved are of general interest for human pain research and as analgesic targets. Comprehensive genetic testing is the key to early diagnosis and adaptation of clinical management.

Highlights

  • IntroductionDifferent subtypes of cutaneous afferent nerves mediate temperature, touch, pressure, vibration, or pain

  • Peripheral sensory nerves transmit stimuli from the environment

  • Respective Mendelian disorders with pain loss are classified as congenital insensitivity to pain (CIP) or hereditary sensory and autonomic neuropathy (HSAN), whereas disorders with increased pain include primary erythromelalgia, familial episodic pain syndromes, and small fiber neuropathies (SFN)

Read more

Summary

Introduction

Different subtypes of cutaneous afferent nerves mediate temperature, touch, pressure, vibration, or pain. The latter is mediated by small Aδ-fibers and unmyeli-. Sensory neurons are highly specialized since they bridge a distance of up to one meter between the skin and their central projections in the spinal cord (Figure 1). They are equipped with a large repertoire of transport proteins, neurotrophin receptors, and ion channels that are involved in the development, long-term survival, and excitability of sensory neurons. In this review on human Mendelian nociception we will discuss clinical symptoms, genes, pathomechanisms, and how these data have been used for novel analgesic development

Pain loss
Childhood Congenital Congenital
Adulthood Childhood Congenital
Type of mutation
Drug candidate
Analgesic targets derived from monogenic pain disorders
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call